Rhythm Pharmaceuticals (RYTM) Invested Capital (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Invested Capital of $133.0 million for Q1 2026, up 547.79% year-over-year from $20.5 million in Q1 2025, and down 9.11% on a QoQ basis from $146.4 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) has 11 years of Invested Capital data on file, last reported at $133.0 million in Q1 2026.
- Quarterly Invested Capital rose 547.79% year-over-year to $133.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.0 million (up 547.79% YoY) and the FY2025 annual result came in at $146.4 million, up 528.99% from the prior year.
- Invested Capital fell to $133.0 million in Q1 2026 per RYTM's latest filing, from $146.4 million in the prior quarter.
- Across five years, Invested Capital topped out at $354.2 million in Q3 2022 and bottomed at -$8.1 million in Q2 2025.
- The 5-year median for Invested Capital is $154.4 million (2025), against an average of $143.2 million.
- Peak annual rise in Invested Capital reached 1276.49% in 2025, while the deepest fall reached 120.66% in 2025.
- Tracing RYTM's Invested Capital over 5 years: stood at $264.3 million in 2022, then sank by 35.76% to $169.8 million in 2023, then plunged by 86.29% to $23.3 million in 2024, then soared by 528.99% to $146.4 million in 2025, then retreated by 9.11% to $133.0 million in 2026.
- Per Business Quant, the three latest RYTM Invested Capital figures stand at $133.0 million (Q1 2026), $146.4 million (Q4 2025), and $154.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Rhythm Pharmaceuticals | 6.00 Bn | 5.66 Bn | 52.96 Mn | 133.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.04 Mn |
| Dec 31, 2025 | 146.37 Mn |
| Sep 30, 2025 | 154.37 Mn |
| Jun 30, 2025 | -8.13 Mn |
| Mar 31, 2025 | 20.54 Mn |
| Dec 31, 2024 | 23.27 Mn |
| Sep 30, 2024 | 11.22 Mn |
| Jun 30, 2024 | 39.34 Mn |
| Mar 31, 2024 | 61.58 Mn |
| Dec 31, 2023 | 169.76 Mn |
| Sep 30, 2023 | 197.47 Mn |
| Jun 30, 2023 | 182.29 Mn |
| Mar 31, 2023 | 219.76 Mn |
| Dec 31, 2022 | 264.26 Mn |
| Sep 30, 2022 | 354.16 Mn |
| Jun 30, 2022 | 229.90 Mn |
| Mar 31, 2022 | 235.77 Mn |
| Dec 31, 2021 | 284.15 Mn |
| Sep 30, 2021 | 322.26 Mn |
| Jun 30, 2021 | 351.69 Mn |
| Mar 31, 2021 | 380.95 Mn |
| Dec 31, 2020 | 166.53 Mn |
| Sep 30, 2020 | 196.94 Mn |
| Jun 30, 2020 | 225.75 Mn |
| Mar 31, 2020 | 253.10 Mn |
| Dec 31, 2019 | 281.02 Mn |
| Sep 30, 2019 | 149.12 Mn |
| Jun 30, 2019 | 181.47 Mn |
| Mar 31, 2019 | 220.49 Mn |
| Dec 31, 2018 | 246.26 Mn |
| Sep 30, 2018 | 269.64 Mn |
| Jun 30, 2018 | 284.32 Mn |
| Mar 31, 2018 | 133.66 Mn |
| Dec 31, 2017 | 144.79 Mn |
| Sep 30, 2017 | -51.86 Mn |
| Dec 31, 2016 | -32.60 Mn |